USD 6.06 Billion Potential Growth in ENT Devices Market|17,000+ Technavio Reports – QNT Press Release

[ad_1]

NEW YORK, Jan. 29, 2022 /PRNewswire/ — The latest market outlook report titled “ENT Devices Market by Product and Geography – Forecast and Analysis 2021-2025” has been added to Technavio’s catalog. This recent market analysis report identifies the market to witness a potential growth difference of USD 6.06 billion from 2020 to 2025. The ENT devices market is anticipated to record an accelerating growth momentum at a CAGR of 4.71% during this period.

Unlock more information on the YOY growth rate, as you Read our FREE Sample!

Parent Market Overview

Technavio categorizes the ENT devices market as a part of the healthcare equipment market within the global healthcare industry. The growth of the healthcare equipment market is attributed to increasing life expectancy, surging cases of chronic conditions, and expanding access to improved healthcare in emerging economies. Technavio calculates the ENT devices market size based on combined revenue generated by companies that are engaged in the provision of all types of healthcare equipment and solutions.

Understand the ENT Devices Market Hierarchy and Gain Further Insights by Downloading Our Samples!

Market Competitive Landscape

The ENT devices market is concentrated. The market is characterized by the presence of established players such as Medtronic Plc, Cochlear Limited, OLYMPUS, Smith & Nephew, and Siemens Healthineers. The market is competitive, as many regional players are competing with the key players . These regional players provide their products at an economical price as compared to global companies creating consistent competition in low-end markets. Furthermore, manufacturers are investing in product development and product expansion in strengthening their product portfolio and geographical reach.

Technavio has classified the industry-focused market players into dominant and strong players based on their annual revenues and market shares in this report. Some of the key players covered in this report include Cochlear Ltd., Demant AS, HOYA Corp., Johnson and Johnson Inc., KARL STORZ SE and Co. KG, Lateral Medical, Medtronic Plc, Olympus Corp., Siemens Healthineers AG, and WS Audiology AS among others.

Strategic Initiatives and Products launches

  • Cochlear Ltd. – The company offers hearing aid solutions across Americas, EMEA, and Asia Pacific. The company offer ENT device namely Nucleus Implants.
  • Demant AS: The company offers hearing devices, hearing implants, and diagnostics. They offer ENT device namely Oticon.
  • Johnson and Johnson Inc.: The company operates in key business segments including consumer, pharmaceutical, and medical devices. The company offer ENT device namely RELIEVA TRACT Nasal Dilation System.

For more insights on competitive strategies and market share of over 20 companies discussed in detail, Get Our Sample Report Right Here!

Value Chain Insights

Vendors in the market can leverage and formulate effective strategies from the ENT Devices Market Value …

Full story available on Benzinga.com

[ad_2]

Source link